NO911051D0 - Fremgangsmaate for fremstilling av nye ascorbinsyrederivater. - Google Patents

Fremgangsmaate for fremstilling av nye ascorbinsyrederivater.

Info

Publication number
NO911051D0
NO911051D0 NO911051A NO911051A NO911051D0 NO 911051 D0 NO911051 D0 NO 911051D0 NO 911051 A NO911051 A NO 911051A NO 911051 A NO911051 A NO 911051A NO 911051 D0 NO911051 D0 NO 911051D0
Authority
NO
Norway
Prior art keywords
preparation
procedure
ascorbic acid
acid derivatives
new ascorbic
Prior art date
Application number
NO911051A
Other languages
English (en)
Other versions
NO911051L (no
NO177705B (no
NO177705C (no
Inventor
Gilbert Marciniak
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911051D0 publication Critical patent/NO911051D0/no
Publication of NO911051L publication Critical patent/NO911051L/no
Publication of NO177705B publication Critical patent/NO177705B/no
Publication of NO177705C publication Critical patent/NO177705C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
NO911051A 1990-03-16 1991-03-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive ascorbinsyrederivater NO177705C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90400731A EP0446539A1 (en) 1990-03-16 1990-03-16 Novel ascorbic acid derivatives

Publications (4)

Publication Number Publication Date
NO911051D0 true NO911051D0 (no) 1991-03-15
NO911051L NO911051L (no) 1991-09-17
NO177705B NO177705B (no) 1995-07-31
NO177705C NO177705C (no) 1995-11-08

Family

ID=8205691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911051A NO177705C (no) 1990-03-16 1991-03-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive ascorbinsyrederivater

Country Status (21)

Country Link
US (1) US5175188A (no)
EP (2) EP0446539A1 (no)
JP (1) JP3029055B2 (no)
KR (1) KR0171190B1 (no)
CN (1) CN1034415C (no)
AT (1) ATE137230T1 (no)
AU (1) AU632907B2 (no)
CA (1) CA2038416C (no)
DE (1) DE69118955T2 (no)
DK (1) DK0447325T5 (no)
ES (1) ES2089159T3 (no)
FI (1) FI97884C (no)
GR (1) GR3020411T3 (no)
HU (1) HU208004B (no)
IE (1) IE910879A1 (no)
IL (1) IL97574A (no)
NO (1) NO177705C (no)
NZ (1) NZ237400A (no)
PT (1) PT97041B (no)
TW (1) TW213455B (no)
ZA (1) ZA911994B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5559251A (en) * 1993-02-05 1996-09-24 Pliva, Farmaceutska Derivatives of amino-ascorbic acid, the processes for their preparation and use
HRP930131A2 (en) * 1993-02-05 1997-02-28 Bozidar Suskovic Amino-ascorbic acid derivatives, process for the preparation and use thereof
FR2946252B1 (fr) * 2009-06-08 2011-07-29 Fabre Pierre Dermo Cosmetique Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368330A (en) * 1981-04-30 1983-01-11 Pfizer Inc. Derivatives of L-ascorbic acid and D-erythorbic acid
IL67646A0 (en) * 1982-01-15 1983-05-15 Lilly Co Eli Ascorbic acid ethers and related compounds
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production
JP2515556B2 (ja) * 1986-08-29 1996-07-10 武田薬品工業株式会社 ヒドロキシブテノライド誘導体およびその製造法
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.

Also Published As

Publication number Publication date
DE69118955T2 (de) 1996-09-19
HUT56559A (en) 1991-09-30
NO911051L (no) 1991-09-17
FI97884C (fi) 1997-03-10
EP0446539A1 (en) 1991-09-18
EP0447325A1 (en) 1991-09-18
GR3020411T3 (en) 1996-09-30
JPH04234869A (ja) 1992-08-24
HU208004B (en) 1993-07-28
CN1034415C (zh) 1997-04-02
IL97574A0 (en) 1992-06-21
NZ237400A (en) 1993-05-26
PT97041B (pt) 1998-07-31
NO177705B (no) 1995-07-31
AU632907B2 (en) 1993-01-14
CN1054978A (zh) 1991-10-02
EP0447325B1 (en) 1996-04-24
KR0171190B1 (ko) 1999-02-01
TW213455B (no) 1993-09-21
CA2038416C (en) 2003-03-11
PT97041A (pt) 1991-10-31
FI911282A0 (fi) 1991-03-15
ES2089159T3 (es) 1996-10-01
JP3029055B2 (ja) 2000-04-04
DE69118955D1 (de) 1996-05-30
NO177705C (no) 1995-11-08
FI911282A (fi) 1991-09-17
ZA911994B (en) 1991-12-24
FI97884B (fi) 1996-11-29
IE910879A1 (en) 1991-09-25
KR910016732A (ko) 1991-11-05
ATE137230T1 (de) 1996-05-15
CA2038416A1 (en) 1991-09-17
DK0447325T5 (da) 1996-05-28
US5175188A (en) 1992-12-29
IL97574A (en) 1995-10-31
AU7287891A (en) 1991-10-10

Similar Documents

Publication Publication Date Title
ES2080900T3 (es) Derivados piranicos utiles como inhibidores de 5-lipoxigenasa.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
FI924424A0 (fi) Hjaertskyddande tokoferolanaloger.
DK0437030T3 (da) Anvendelse af 4-substituerede imidazoler til nedsættelse af det intraoculære tryk
MX24839A (es) 3-arilcarbonil-1-aminoalquilo-1h-indoles, proceso para su preparacion y composicion farmaceutica quelos contiene.
DE69413118D1 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
NO911051D0 (no) Fremgangsmaate for fremstilling av nye ascorbinsyrederivater.
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.
NO933328L (no) Nye thiomarinolderivater og fremgangsmåte for deres fremstilling
DE3880304D1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
DE69222143D1 (de) Indanderivate
ITMI920082A1 (it) Derivati solforati di acidi biliari
ATE44144T1 (de) 6h-dibenzo(b,e)(1,4)oxathiepin-verbindungen.
ATE155479T1 (de) Neue cytarabin-derivate, ihre herstellung und verwendung
ATE168683T1 (de) Substituierte iminoacetonitrile mit myokardprotektiver wirkung